26.07.2023 12:51:57
|
Quest Diagnostics Q2 Profit Increases, beats estimates
(RTTNews) - Quest Diagnostics (DGX) released a profit for its second quarter that increased from the same period last year and beat the Street estimates.
The company's bottom line totaled $235 million, or $2.05 per share. This compares with $234 million, or $1.96 per share, in last year's second quarter.
Excluding items, Quest Diagnostics reported adjusted earnings of $263 million or $2.30 per share for the period.
Analysts on average had expected the company to earn $2.27 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 4.5% to $2.34 billion from $2.45 billion last year.
Quest Diagnostics earnings at a glance (GAAP) :
-Earnings (Q2): $235 Mln. vs. $234 Mln. last year. -EPS (Q2): $2.05 vs. $1.96 last year. -Analyst Estimate: $2.27 -Revenue (Q2): $2.34 Bln vs. $2.45 Bln last year.
-Guidance: Full year EPS guidance: $8.50 - $8.90 Full year revenue guidance: $9.12 - $9.22 Bln
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Quest Diagnostics Inc. | 156,05 | -0,76% |
|